Jaguar Health (JAGX) Inventory Average (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Inventory Average of $8.2 million for Q1 2026, down 21.44% year-over-year from $10.4 million in Q1 2025, and down 14.61% quarter-over-quarter from $9.6 million in Q4 2025.
Jaguar Health (JAGX) Inventory Average (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Inventory Average for 12 consecutive years, with $8.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average fell 21.44% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $8.2 million (down 21.44% YoY), while the FY2025 annual figure was $9.5 million, down 3.02% from the prior year.
- Inventory Average slipped to $8.2 million in Q1 2026 per JAGX's latest filing, from $9.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $10.7 million in Q3 2025 and bottomed at $4.9 million in Q1 2022.
- Historically, Inventory Average has averaged $8.5 million across 5 years, with a median of $8.8 million in 2023.
- Annual changes were most pronounced in 2022 — Inventory Average jumped 86.79% — and 2026, when it slipped 21.44%.
- Jaguar Health's Inventory Average stood at $6.8 million in 2022, then advanced by 28.94% to $8.8 million in 2023, then rose by 13.95% to $10.0 million in 2024, then retreated by 3.96% to $9.6 million in 2025, then decreased by 14.61% to $8.2 million in 2026.
- Business Quant data shows JAGX's Inventory Average at $8.2 million in Q1 2026, $9.6 million in Q4 2025, and $10.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | - |
| 10 | Jaguar Health | 459,102.90 | -9.60 Mn | 19.11 Mn | 8.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.21 Mn |
| Dec 31, 2025 | 9.61 Mn |
| Sep 30, 2025 | 10.67 Mn |
| Jun 30, 2025 | 10.64 Mn |
| Mar 31, 2025 | 10.45 Mn |
| Dec 31, 2024 | 10.01 Mn |
| Sep 30, 2024 | 9.62 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Mar 31, 2024 | 9.10 Mn |
| Dec 31, 2023 | 8.78 Mn |
| Sep 30, 2023 | 8.32 Mn |
| Jun 30, 2023 | 8.47 Mn |
| Mar 31, 2023 | 7.85 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Sep 30, 2022 | 6.67 Mn |
| Jun 30, 2022 | 5.81 Mn |
| Mar 31, 2022 | 4.89 Mn |
| Dec 31, 2021 | 4.71 Mn |
| Sep 30, 2021 | 3.96 Mn |
| Jun 30, 2021 | 3.11 Mn |